CLM-IN01
Insomnia
Pre-commercial (UKCA/CE marked)Active
Key Facts
About Closed Loop Medicine
Closed Loop Medicine is a clinical-stage digital therapeutics company pioneering a platform that integrates AI-driven, adaptive drug dosing with companion digital software. Its core strategy involves partnering with pharmaceutical companies to develop and commercialize personalized, combination prescription products, with an initial commercial and clinical focus on GLP-1 therapies for obesity and related conditions. The company has launched its first product in the U.S., secured key patents, and is actively building a pipeline in other chronic disease areas like hypertension and insomnia. It operates as a private, venture-backed firm leveraging regulatory designations for its software as a medical device.
View full company profileTherapeutic Areas
Other Insomnia Drugs
| Drug | Company | Phase |
|---|---|---|
| Cannabidiol Soft‑Gel Capsule | Avecho Biotechnology | Phase 3 |
| Nexalin Device | Nexalin Technology | Pivotal Trial |
| SILENOR | Currax Pharmaceuticals | Approved |
| Levroso Long (Diphenhydramine/Melatonin) | NovaMedica | Approved |
| Insomnia Studies | Pacific Clinical Research Medical Group | Phase 2/3 |
| HS-10384 | Hansoh Pharma | Phase III |
| CEL-101 (C-122) | Celon Pharma | Phase II |
| CGS-2 | Canopy Growth | Phase II |